An RNA-independent linkage of noncoding transcription to long-range enhancer function

Molecular and Cellular Biology

Volumn 32, Issue 10, 2012, Pages 2020-2029

  Yoo, Eung Jae ^a   Cooke, Nancy E ^a   Liebhaber, Stephen A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; RNA; UNTRANSLATED RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE LOCUS; HYPOPHYSIS; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION; STRUCTURE ANALYSIS;

ANIMALS; ENHANCER ELEMENTS, GENETIC; HUMAN GROWTH HORMONE; HUMANS; LOCUS CONTROL REGION; MICE; MICE, TRANSGENIC; OOCYTES; PITUITARY GLAND; RNA; TRANSCRIPTIONAL ACTIVATION; TRANSGENES;

MAMMALIA;

EID: 84861402632     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06650-11     Document Type: Article

References (53)

1. Andersen B, Rosenfeld MG. 2001. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endo. Rev. 22:2-35.
2. Bennani-Baiti IM, et al. 1998. DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression. Proc. Natl. Acad. Sci. U. S. A. 95:10655-10660.
3. Bennani-Baiti IM, Cooke NE, Liebhaber SA. 1998. Physical linkage of the human growth hormone gene cluster and the CD79b (Ig_/B29) gene. Genomics 48:258-264.
4. Bulger M, Groudine M. 2010. Enhancers: the abundance and function of regulatory sequences beyond promoters. Dev. Biol. 339:250-257.
5. Cajiao I, Zhang A, Yoo EJ, Cooke NE, Liebhaber SA. 2004. Bystander gene activation by a locus control region. EMBO J. 23:3854-3863.
6. Carter D, Chakalova L, Osborne CS, Dai Y-F, Fraser P. 2002. Longrange chromatin regulatory interactions in vivo. Nat. Genet. 32:623-626.
7. Chan SW, et al. 2004. RNA silencing genes control de novo DNA methylation. Science 303:1336.
8. Corcoran AE. 2010. The epigenetic role of non-coding RNA transcription and nuclear organization in immunoglobulin repertoire generation. Semin. Immunol. 22:353-361.
9. Dattani M, Preece M. 2004. Growth hormone deficiency and related disorders: insights into causation, diagnosis, and treatment. Lancet 363: 1977-1986.
10. Dean A. 2006. On a chromosome far, far away: LCRs and gene expression. Trends Genet. 22:38-45.
11. Dekker J, Rippe K, Dekker M, Kleckner N. 2002. Capturing chromosome conformation. Science 295:1306-1311.
12. Drewell RA, Bae E, Burr J, Lewis EB. 2002. Transcription defines the embryonic domains of cis-regulatory activity at the Drosophila bithorax complex. Proc. Natl. Acad. Sci. U. S. A. 99:16853-16858.
13. Fu Q, Manolagas SC, O'Brien CA. 2006. Parathyroid hormone controls receptor activator of NF-_B ligand gene expression via a distant transcriptional enhancer. Mol. Cell. Biol. 26:6453-6468.
14. Gage PJ, Suh H, Camper SA. 1999. The bicoid-related Pitx gene family in development. Mamm. Genome. 10:197-200.
15. Gong S, et al. 2003. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425:917-925.
16. Gribnau J, Diderich K, Pruzina S, Calzolari R, Fraser P. 2000. Intergenic transcription and developmental remodeling of chromatin subdomains in the human _-globin locus. Mol. Cell 5:377-386.
17. Hatzis P, Talianidis I. 2002. Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol. Cell 10: 1467-1477.
18. Heard E. 2004. Recent advances in X-chromosome inactivation. Curr. Opin. Cell Biol. 16:247-255.
19. Heintzman ND, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39:311-318.
20. Heintzman ND, et al. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459:108-112.
21. Hermanson GG, Eisenberg D, Kincade PW, Wall R. 1998. B29: a member of the immunoglobulin gene superfamily exclusively expressed on beta-lineage cells. Proc. Natl. Acad. Sci. U. S. A. 85:6890-6894.
22. Ho Y, Elefant F, Cooke NE, Liebhaber SA. 2002. A defined locus control region determinant links chromatin domain acetylation with long-range gene activation. Mol. Cell 9:291-302.
23. Ho Y, Elefant F, Liebhaber SA, Cooke NE. 2006. Locus control region transcription plays an active role in long-range gene activation. Mol. Cell 23:365-375.
24. Ho Y, Tadevosyan A, Liebhaber SA, Cooke NE. 2008. The juxtaposition of a promoter with a locus control region transcriptional domain activates gene expression. EMBO Rep. 9:891-898.
25. Huarte M, et al. 2010. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142:409-419.
26. Jing H, et al. 2008. Exchange of GATA factors mediates transitions in looped chromatin organization at a developmentally regulated gene locus. Mol. Cell 29:232-242.
27. Jones BK, Monks BR, Liebhaber SA, Cooke NE. 1995. The human growth hormone gene is regulated by a multicomponent locus control region. Mol. Cell. Biol. 15:7010-7021.
28. Kagey MH, et al. 2010. Mediator and cohesin connect gene expression and chromatin architecture. Nature 467:430-435.
29. Kawasaki H, Taira K. 2005. Transcriptional gene silencing by short interfering RNAs. Curr. Opin. Mol. Ther. 7:125-131.
30. Kim T-K, et al. 2010. Widespread transcription at neuronal activityregulated enhancers. Nature 465:182-187.
31. Koch F, Jourquin F, Ferrier P, Andrau J-C. 2008. Genome-wide RNA polymerase II: not genes only! Trends Biochem. Sci. 33:265-273.
32. Ling J, et al. 2004. HS2 enhancer function is blocked by a transcriptionalterminator inserted between the enhancer and the promoter. J. Biol. Chem. 279:51704-51713.
33. Masternak K, Peyraud N, Krawczyk M, Barras E, Reith W. 2003. Chromatin remodeling and extragenic transcription at the MHC class II locus control region. Nat. Immunol. 4:132-137.
34. Meyer MB, Goetsch PD, Pike JW. 2010. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1α,25-dihydroxyvitamin D3. J. Biol. Chem. 285:1599-15610.
35. Miele A, Dekker J. 2008. Long-range chromosomal interactions and gene regulation. Mol. Biosyst. 4:1046-1057.
36. Mitchell JA, Fraser P. 2008. Transcription factories are nuclear subcompartments that remain in the absence of transcription. Genes Dev. 22:20-25.
37. Nissim S, Allard P, Bandyopadhyay A, Harfe BD, Tabin CJ. 2007. Characterization of a novel ectodermal signaling center regulating Tbx2 and Shh in the vertebrate limb. Dev. Biol. 304:9-21.
38. Nolis IK, et al. 2009. Transcription factors mediate long-range enhancerpromoter interactions. Proc. Natl. Acad. Sci. U. S. A. 106:20222-20227.
39. Omori SA, Wall R. 1993. Multiple motifs regulate the B cell-specific promoter of the B29 gene. Proc. Natl. Acad. Sci. U. S. A. 90:11723-11727.
40. Ørom UA, et al. 2010. Long noncoding RNAs with enhancer-like function in human cells. Cell 143:46-58.
41. Shewchuk BM, Asa SL, Cooke NE, Liebhaber SA. 1999. Pit-1 binding sites at the somatotrope-specific DNase I hypersensitive sites I, II of the human growth hormone locus control region are essential for in vivo hGH-N gene activation. J. Biol. Chem. 274:35725-35733.
42. Shewchuk BM, Liebhaber SA, Cooke NE. 2002. Specification of unique Pit-1 activity in the hGH locus control region. Proc. Natl. Acad. Sci. U. S. A. 99:11784-11789.
43. Soshnikova N, Montavon T, Leleu M, Galjart N, Duboule D. 2010. Functional analysis of CTCF during mammalian limb development. Cell Dev. 19:819-830.
44. Su Y, Liebhaber SA, Cooke NE. 2000. Human growth hormone gene cluster locus control region supports position-independent pituitary- and placenta-specific expression in the transgenic mouse. J. Biol. Chem. 275: 7902-7909.
45. Szutorisz H, and Dillon N, Tora L. 2005. The role of enhancers as centres for general transcription factor recruitment. Trends Biochem. Sci. 30:593-599.
46. Thompson AA, et al. 1996. The promoter and 5= flanking sequences controlling human B29 gene expression. Blood 87:666-673.
47. Tolhuis B, Palstra RJ, Splinter E, Grosveld F, de Laat W. 2002. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol. Cell 10:1453-1465.
48. Vernimmen D, De Gobbi M, Sloane-Stanley JA, Wood WG, Higgs DR. 2007. Long-range chromosomal interactions regulate the timing of the transition between poised and active gene expression. EMBO J. 26:2041-2051.
49. Yoo EJ, et al. 2006. Tissue-specific chromatin modifications at a multigene locus generate asymmetric transcriptional interactions. Mol. Cell. Biol. 26:5569-5579.
50. Zhao H, Dean A. 2004. An insulator blocks spreading of histone acetylation and interferes withRNApolymerase II transfer between and enhancer and gene. Nucleic Acids Res. 32:4903-4919.
51. Zhu X, et al. 2007. A facilitated tracking and transcription mechanism of long-range enhancer function. Nucleic Acids Res. 35:5532-5544.
52. Zhu X, Cleiberman AS, Rosenfeld MG. 2007. Molecular physiology of pituitary development: signaling and transcriptional networks. Physiol. Rev. 87:933-963.
53. Xu L, et al. 1998. Signal-specific coactivator domain requirements for Pit-1 activation. Nature 395:301-306.